Biotricity Inc (NASDAQ:BTCY) — Market Cap & Net Worth
Market Cap & Net Worth: Biotricity Inc (BTCY)
Biotricity Inc (NASDAQ:BTCY) has a market capitalization of $2.92 Million ($2.92 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29499 globally and #5941 in its home market, demonstrating a 3.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biotricity Inc's stock price $0.11 by its total outstanding shares 26567769 (26.57 Million). Review BTCY FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
Biotricity Inc Market Cap History: 2016 to 2026
Biotricity Inc's market capitalization history from 2016 to 2026. Data shows change from $411.27 Million to $2.92 Million (-37.86% CAGR).
Biotricity Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biotricity Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.56x
Biotricity Inc's market cap is 0.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $100.44 Million | $398.20K | -$8.59 Million | 252.24x | N/A |
| 2020 | $117.68 Million | $1.42 Million | -$11.07 Million | 83.01x | N/A |
| 2021 | $634.44 Million | $3.38 Million | -$15.49 Million | 187.44x | N/A |
| 2022 | $71.41 Million | $7.65 Million | -$29.13 Million | 9.33x | N/A |
| 2023 | $30.55 Million | $9.64 Million | -$18.66 Million | 3.17x | N/A |
| 2024 | $7.44 Million | $12.06 Million | -$14.09 Million | 0.62x | N/A |
| 2025 | $7.68 Million | $13.79 Million | -$8.42 Million | 0.56x | N/A |
Competitor Companies of BTCY by Market Capitalization
Companies near Biotricity Inc in the global market cap rankings as of August 3, 2026.
Key companies related to Biotricity Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Biotricity Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, Biotricity Inc's market cap moved from $411.27 Million to $ 2.92 Million, with a yearly change of -37.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.92 Million | -61.92% |
| 2025 | $7.68 Million | +3.18% |
| 2024 | $7.44 Million | -75.65% |
| 2023 | $30.55 Million | -57.22% |
| 2022 | $71.41 Million | -88.74% |
| 2021 | $634.44 Million | +439.11% |
| 2020 | $117.68 Million | +17.16% |
| 2019 | $100.44 Million | +31.27% |
| 2018 | $76.52 Million | -93.68% |
| 2017 | $1.21 Billion | +194.22% |
| 2016 | $411.27 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Biotricity Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.92 Million USD |
| MoneyControl | $2.92 Million USD |
| MarketWatch | $2.92 Million USD |
| marketcap.company | $2.92 Million USD |
| Reuters | $2.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Biotricity Inc
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes … Read more